Using our patented technology (LTE-qMSP), we can detect colorectal, bladder, and lung cancer early. This is done through PCR, where methylated DNA are used as biomarkers. Even with a minute amount of sample, the tests maintain a high sensitivity and spec
screening examinations of the skin, nails, and mucous membranes by physicians, and careful long-term Surveillance of patients determined in be al high risk for CM 'based on identifiable historic and phenotypic traits are having an immediate positive impact on CM. related mortality and CM-related ...
3.U.S. Food and Drug Administration. (2018). Enforcement policy—OTCsunscreen drug products marketed without an approved application.Center for Drug Evaluation and Research, Guideline for Industry.https:// www. fda. gov/ regul atory- infor m...
[75] Wang X, Sun Y, Xu Y, et al. Mini-patient-derived xenograft assay based on microfluidic technology promises to be an effective tool for screening individualized chemotherapy regimens for advanced non-small cell lung c...